KURA logo

KURA
Kura Oncology Inc

3,619
Mkt Cap
$760.52M
Volume
4.39M
52W High
$12.49
52W Low
$5.41
PE Ratio
-2.71
KURA Fundamentals
Price
$8.61
Prev Close
$8.34
Open
$8.15
50D MA
$8.40
Beta
1.06
Avg. Volume
1.53M
EPS (Annual)
-$3.18
P/B
4.34
Rev/Employee
$259,546.15
$264.17
Loading...
Loading...
News
all
press releases
Kura Oncology (NASDAQ:KURA) Sees Unusually-High Trading Volume - Time to Buy?
Kura Oncology (NASDAQ:KURA) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of "Moderate Buy" from Brokerages
Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twelve analysts that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation...
MarketBeat·10d ago
News Placeholder
Mizuho Cuts Kura Oncology (NASDAQ:KURA) Price Target to $25.00
Mizuho decreased their price target on shares of Kura Oncology from $30.00 to $25.00 and set an "outperform" rating for the company in a research note on Tuesday...
MarketBeat·11d ago
News Placeholder
Implied Volatility Surging for Kura Oncology Stock Options
Investors need to pay close attention to Kura Oncology stock based on the movements in the options market lately.
Zacks·23d ago
News Placeholder
FY2027 EPS Forecast for Kura Oncology Lowered by Analyst
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Brookline Capital Acquisition dropped their FY2027 earnings estimates for Kura Oncology in a note issued to investors on Thursday...
MarketBeat·26d ago
News Placeholder
Kura Oncology (NASDAQ:KURA) Given New $36.00 Price Target at Wedbush
Wedbush reduced their price target on Kura Oncology from $38.00 to $36.00 and set an "outperform" rating for the company in a research report on Friday...
MarketBeat·29d ago
News Placeholder
Kura Oncology Q4 Earnings Call Highlights
Kura Oncology (NASDAQ:KURA) executives used the company's fourth-quarter and fiscal 2025 earnings call to highlight what CEO Troy Wilson called a defining year, driven by the FDA approval of Komzifti...
MarketBeat·29d ago
News Placeholder
Kura Oncology (NASDAQ:KURA) Shares Gap Down After Earnings Miss
Kura Oncology (NASDAQ:KURA) Shares Gap Down Following Weak Earnings...
MarketBeat·30d ago
News Placeholder
Kura Oncology (NASDAQ:KURA) Releases Earnings Results, Misses Estimates By $0.50 EPS
Kura Oncology (NASDAQ:KURA - Get Free Report) released its earnings results on Thursday. The company reported ($0.92) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.50...
MarketBeat·30d ago
News Placeholder
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Kura Oncology (KURA) delivered earnings and revenue surprises of -28.67% and -41.85%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·30d ago
<
1
2
...
>

Latest KURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.